NCT05289440

Brief Summary

Some studies have reported that intravenous esketamine reduce postoperative pain intensity. The investigators investigated whether esketamine could improve the the quality of recovery after modified radical mastectomy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
105

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 10, 2022

Completed
5 days until next milestone

Study Start

First participant enrolled

March 15, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 21, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2022

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 20, 2022

Completed
Last Updated

November 9, 2022

Status Verified

November 1, 2022

Enrollment Period

6 months

First QC Date

March 10, 2022

Last Update Submit

November 8, 2022

Conditions

Keywords

EsketamineThe quality of recovery

Outcome Measures

Primary Outcomes (1)

  • Quality of recovery scores (QoR-15)

    Our primary outcome was quality of recovery scores (QoR-15) 1 day after operation

    1 day after operation

Secondary Outcomes (1)

  • Pain visual analogue scale scores

    The first 48 hours after operation

Study Arms (3)

Low-dose esketamine infusion on the quality of recovery after radical mastectomy

EXPERIMENTAL

Patients received a bolus infusion of esketamine (0.5 mg/kg) before cutting the skin, and then esketamine was infused at a rate of 2 µg/kg/min until before suture the skin.

Drug: Low-dose esketamine infusionDrug: High-dose esketamine infusionDrug: Saline infusion

High-dose esketamine infusion on the quality of recovery after radical mastectomy

EXPERIMENTAL

Patients received a bolus infusion of esketamine (0.5 mg/kg) before cutting the skin, and then esketamine was infused at a rate of 4 µg/kg/min until before suture the skin.

Drug: Low-dose esketamine infusionDrug: High-dose esketamine infusionDrug: Saline infusion

Saline infusion on the quality of recovery after radical mastectomy

EXPERIMENTAL

Patients received a bolus infusion of the same volume saline before cutting the skin, and then the same volume saline was infused until before suture the skin.

Drug: Low-dose esketamine infusionDrug: High-dose esketamine infusionDrug: Saline infusion

Interventions

Patients received a bolus infusion of esketamine (0.5 mg/kg) before cutting the skin, and then esketamine was infused at a rate of 2 µg/kg/min until before suture the skin.

High-dose esketamine infusion on the quality of recovery after radical mastectomyLow-dose esketamine infusion on the quality of recovery after radical mastectomySaline infusion on the quality of recovery after radical mastectomy

Patients received a bolus infusion of esketamine (0.5 mg/kg) before cutting the skin, and then esketamine was infused at a rate of 4 µg/kg/min until before suture the skin.

High-dose esketamine infusion on the quality of recovery after radical mastectomyLow-dose esketamine infusion on the quality of recovery after radical mastectomySaline infusion on the quality of recovery after radical mastectomy

Patients received a bolus infusion of the same volume saline before cutting the skin, and then the same volume saline was infused until before suture the skin.

High-dose esketamine infusion on the quality of recovery after radical mastectomyLow-dose esketamine infusion on the quality of recovery after radical mastectomySaline infusion on the quality of recovery after radical mastectomy

Eligibility Criteria

Age30 Years - 60 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • American Society of Anesthesiologists (ASA) physical status
  • Scheduled for elective modified radical mastectomy

You may not qualify if:

  • Severe respiratory disease
  • Renal or hepatic insufficiency
  • History of preoperative psychiatric
  • Preoperative hypertension
  • Preoperative history of chronic pain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anqing Hospital Anesthesiology

Anqing, Anhui, 246000, China

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 10, 2022

First Posted

March 21, 2022

Study Start

March 15, 2022

Primary Completion

September 15, 2022

Study Completion

September 20, 2022

Last Updated

November 9, 2022

Record last verified: 2022-11

Locations